We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

23 hedge funds and large institutions have $2.24M invested in Bio-Path Holdings Inc in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

18% less capital invested

Capital invested by funds: $2.73M → $2.24M (-$492K)

21% less funds holding

Funds holding: 2923 (-6)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
23
Holders Change
-6
Holders Change %
-20.69%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
7
Reduced
5
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
-$113K -140 Closed
Creative Planning
27
Creative Planning
Kansas
-$10K -13 Closed
State Street
28
State Street
Massachusetts
-$10K -12 Closed
IIC
29
Ironwood Investment Counsel
Arizona
-$9K -11 Closed
TSS
30
Two Sigma Securities
New York
-$7K -9 Closed
VF
31
Virtu Financial
New York
-$6K -8 Closed
BP
32
BBR Partners
New York
-$3K -4 Closed
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
+$780 +1 New

BPTH Hedge Fund Activity: Q1 2018 in Review

23 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2018, worth a combined $2.24M — down 18% from $2.73M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BPTH and 3 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $133K. The largest seller was Anson Funds Management, exiting entirely with an estimated $272K sold.

  • 23 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2018, down from 29 in Q4 2017.
  • Funds reported $2.24M of Bio-Path Holdings Inc stock for Q1 2018, down 18% quarter-over-quarter.
  • 3 funds opened new Bio-Path Holdings Inc positions in Q1 2018 and 9 closed out, a net change of -6 holders.
  • The largest Bio-Path Holdings Inc buyer in Q1 2018 was Renaissance Technologies, an estimated $133K added.
  • The largest Bio-Path Holdings Inc seller in Q1 2018 was Anson Funds Management, an estimated $272K sold.

Based on aggregated 13F filings for Q1 2018.